Login Register Cart 0
Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Calprotectin as a Serodiagnostic Marker for Bacterial Sepsis

Author(s): Zahra Bakhshiani, Saloomeh Fouladi and Faranak Rezaei*

Volume 21, Issue 2, 2023

Published on: 05 October, 2022

Article ID: e290822208188 Pages: 7

DOI: 10.2174/2211352520666220829153943

Price: $65

Abstract

Introduction: Since sepsis is a major global health problem, a rapid and correct diagnosis and the initiation of therapy are essential patient consequences. This study aimed to assess the serum levels of calprotectin and a more widely used sepsis biomarker in the patients with bacterial sepsis (BS).

Methods: Subjects were classified into BS group with the patients who met the sepsis criteria at the beginning of the study and the control group. We investigated the concentrations of biomarkers in 300 blood samples collected at admission from all patients hospitalized in the Fatemeh Al-Zahra Hospital, Najafabad, Isfahan in April 2019 to April 2020.

Results: The microbial etiology in the BS group was confirmed in 35 patients (100%). The most frequently cultivated pathogens were Escherichia coli (n =11). The serum concentrations of calprotectin and CRP were significantly higher in the patients with BS (n= 35) than in the healthy controls (n = 20).

Conclusion: Our results suggest that the serum level of calprotectin could have the substantial added value manage BS which is a reliable biomarker of BS.

Keywords: Bacterial sepsis, serum calprotectin, c-reactive protein, biomarker, microbial etiology, serodiagnostic marker.

Graphical Abstract

[1]
Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.D.; Coopersmith, C.M.; Hotchkiss, R.S.; Levy, M.M.; Marshall, J.C.; Martin, G.S.; Opal, S.M.; Rubenfeld, G.D.; van der Poll, T.; Vincent, J.L.; Angus, D.C. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 2016, 315(8), 801-810.
[http://dx.doi.org/10.1001/jama.2016.0287] [PMID: 26903338]
[2]
Thorrington, D.; Andrews, N.; Stowe, J.; Miller, E.; van Hoek, A.J. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Med., 2018, 16(1), 13.
[http://dx.doi.org/10.1186/s12916-018-1004-z] [PMID: 29415741]
[3]
Martischang, R.; Pires, D.; Masson-Roy, S.; Saito, H.; Pittet, D. Promoting and sustaining a historical and global effort to prevent sepsis: The 2018 World Health Organization save lives: Clean your hands campaign. Crit. Care, 2018, 22(1), 92.
[http://dx.doi.org/10.1186/s13054-018-2011-3]
[4]
Rudd, K.E.; Johnson, S.C.; Agesa, K.M.; Shackelford, K.A.; Tsoi, D.; Kievlan, D.R.; Colombara, D.V.; Ikuta, K.S.; Kissoon, N.; Finfer, S.; Fleischmann-Struzek, C.; Machado, F.R.; Reinhart, K.K.; Rowan, K.; Seymour, C.W.; Watson, R.S.; West, T.E.; Marinho, F.; Hay, S.I.; Lozano, R.; Lopez, A.D.; Angus, D.C.; Murray, C.J.L.; Naghavi, M. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet, 2020, 395(10219), 200-211.
[http://dx.doi.org/10.1016/S0140-6736(19)32989-7] [PMID: 31954465]
[5]
Reinhart, K.; Daniels, R.; Kissoon, N.; Machado, F.R.; Schachter, R.D.; Finfer, S. Recognizing sepsis as a global health priority-A WHO resolution. N. Engl. J. Med., 2017, 377(5), 414-417.
[http://dx.doi.org/10.1056/NEJMp1707170] [PMID: 28658587]
[6]
Chen, A.X.; Simpson, S.Q.; Pallin, D.J. Sepsis guidelines. N. Engl. J. Med., 2019, 380(14), 1369-1371.
[http://dx.doi.org/10.1056/NEJMclde1815472] [PMID: 30943343]
[7]
Liesenfeld, O.; Lehman, L.; Hunfeld, K-P.; Kost, G. Molecular diagnosis of sepsis: New aspects and recent developments. Eur. J. Microbiol. Immunol. (Bp.), 2014, 4(1), 1-25.
[http://dx.doi.org/10.1556/EuJMI.4.2014.1.1] [PMID: 24678402]
[8]
Sweeney, T.E.; Liesenfeld, O.; May, L. Diagnosis of bacterial sepsis: Why are tests for bacteremia not sufficient? Expert Rev. Mol. Diagn., 2019, 19(11), 959-962.
[http://dx.doi.org/10.1080/14737159.2019.1660644] [PMID: 31446810]
[9]
Edgeworth, J.; Gorman, M.; Bennett, R.; Freemont, P.; Hogg, N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem., 1991, 266(12), 7706-7713.
[http://dx.doi.org/10.1016/S0021-9258(20)89506-4] [PMID: 2019594]
[10]
Goebeler, M.; Roth, J.; van den Bos, C.; Ader, G.; Sorg, C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem. J., 1995, 309(Pt 2), 419-424.
[http://dx.doi.org/10.1042/bj3090419] [PMID: 7542868]
[11]
Terrin, G.; Passariello, A.; Manguso, F.; Salvia, G.; Rapacciuolo, L.; Messina, F.; Raimondi, F.; Canani, R.B. Serum calprotectin: An antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin. Dev. Immunol., 2011, 2011, 291085.
[http://dx.doi.org/10.1155/2011/291085] [PMID: 21765851]
[12]
Lipcsey, M.; Hanslin, K.; Stålberg, J.; Smekal, D.; Larsson, A. The time course of calprotectin liberation from human neutrophil granulocytes after Escherichia coli and endotoxin challenge. Innate Immun., 2019, 25(6), 369-373.
[http://dx.doi.org/10.1177/1753425919848476] [PMID: 31109223]
[13]
Ambe, P.C.; Gödde, D.; Bönicke, L.; Papadakis, M.; Störkel, S.; Zirngibl, H. Calprotectin could be a potential biomarker for acute appendicitis. J. Transl. Med., 2016, 14(1), 107.
[http://dx.doi.org/10.1186/s12967-016-0863-3] [PMID: 27118309]
[14]
Mansour, H.E.; Abdullrhman, M.A.; Mobasher, S.A.; El Mallah, R.; Abaza, N.; Hamed, F.; Khalil, A.A.F. Serum calprotectin in rheumatoid arthritis: A promising diagnostic marker, how far is it related to activity and sonographic findings? J. Med. Ultrasound, 2017, 25(1), 40-46.
[http://dx.doi.org/10.1016/j.jmu.2016.11.001] [PMID: 30065453]
[15]
Wang, Q.; Chen, W.; Lin, J. The role of calprotectin in rheumatoid arthritis. J. Transl. Int. Med., 2019, 7(4), 126-131.
[http://dx.doi.org/10.2478/jtim-2019-0026] [PMID: 32010597]
[16]
Decembrino, L.; De Amici, M.; Pozzi, M.; De Silvestri, A.; Stronati, M. Serum calprotectin: A potential biomarker for neonatal sepsis. J. Immunol. Res., 2015, 2015, 147973.
[http://dx.doi.org/10.1155/2015/147973] [PMID: 26380313]
[17]
Bartáková, E.; Štefan, M.; Stráníková, A.; Pospíšilová, L.; Arientová, S.; Beran, O.; Blahutová, M.; Máca, J.; Holub, M. Calprotectin and calgranulin C serum levels in bacterial sepsis. Diagn. Microbiol. Infect. Dis., 2019, 93(3), 219-226.
[http://dx.doi.org/10.1016/j.diagmicrobio.2018.10.006] [PMID: 30420210]
[18]
Larsson, A.; Tydén, J.; Johansson, J.; Lipcsey, M.; Bergquist, M.; Kultima, K.; Mandic-Havelka, A. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scand. J. Clin. Lab. Invest., 2020, 80(2), 156-161.
[http://dx.doi.org/10.1080/00365513.2019.1703216] [PMID: 31841042]
[19]
Megahed, M.M.; Abdel-Fattah, S.; El-Sayed, A.R.; Ahmed, I.E.S. Diagnostic and prognostic value of serum calprotectin in septic shock patients. Science, 2017, 6(3), 32-38.
[20]
Suarez De La Rica, A.; Gilsanz, F.; Maseda, E. Epidemiologic trends of sepsis in western countries. Ann. Transl. Med., 2016, 4(17), 325.
[http://dx.doi.org/10.21037/atm.2016.08.59] [PMID: 27713883]
[21]
Bouza, C.; López-Cuadrado, T.; Saz-Parkinson, Z.; Amate-Blanco, J.M. Epidemiology and recent trends of severe sepsis in Spain: A nationwide population-based analysis (2006-2011). BMC Infect. Dis., 2014, 14(1), 3863.
[http://dx.doi.org/10.1186/s12879-014-0717-7] [PMID: 25528662]
[22]
Vincent, J-L.; Sakr, Y.; Sprung, C.L.; Ranieri, V.M.; Reinhart, K.; Gerlach, H.; Moreno, R.; Carlet, J.; Le Gall, J.R.; Payen, D. Sepsis in European intensive care units: Results of the SOAP study. Crit. Care Med., 2006, 34(2), 344-353.
[http://dx.doi.org/10.1097/01.CCM.0000194725.48928.3A] [PMID: 16424713]
[23]
Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med., 2001, 29(7), 1303-1310.
[http://dx.doi.org/10.1097/00003246-200107000-00002] [PMID: 11445675]
[24]
Pruinelli, L.; Westra, B.L.; Yadav, P.; Hoff, A.; Steinbach, M.; Kumar, V.; Delaney, C.W.; Simon, G. Delay within the 3-hour surviving sepsis campaign guideline on mortality for patients with severe sepsis and septic shock. Crit. Care Med., 2018, 46(4), 500-505.
[http://dx.doi.org/10.1097/CCM.0000000000002949] [PMID: 29298189]
[25]
Kumar, A.; Roberts, D.; Wood, K.E.; Light, B.; Parrillo, J.E.; Sharma, S.; Suppes, R.; Feinstein, D.; Zanotti, S.; Taiberg, L.; Gurka, D.; Kumar, A.; Cheang, M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med., 2006, 34(6), 1589-1596.
[http://dx.doi.org/10.1097/01.CCM.0000217961.75225.E9] [PMID: 16625125]
[26]
Kibe, S.; Adams, K.; Barlow, G. Diagnostic and prognostic biomarkers of sepsis in critical care. J. Antimicrob. Chemother., 2011, 66(Suppl. 2), ii33-ii40.
[http://dx.doi.org/10.1093/jac/dkq523] [PMID: 21398306]
[27]
Póvoa, P.; Coelho, L.; Almeida, E.; Fernandes, A.; Mealha, R.; Moreira, P.; Sabino, H. C-reactive protein as a marker of infection in critically ill patients. Clin. Microbiol. Infect., 2005, 11(2), 101-108.
[http://dx.doi.org/10.1111/j.1469-0691.2004.01044.x] [PMID: 15679483]
[28]
Castelli, G.P.; Pognani, C.; Cita, M.; Stuani, A.; Sgarbi, L.; Paladini, R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: Diagnosis and monitoring of sepsis. Minerva Anestesiol., 2006, 72(1-2), 69-80.
[PMID: 16407808]
[29]
Gao, S.; Yang, Y.; Fu, Y.; Guo, W.; Liu, G. Diagnostic and prognostic value of myeloid-related protein complex 8/14 for sepsis. Am. J. Emerg. Med., 2015, 33(9), 1278-1282.
[http://dx.doi.org/10.1016/j.ajem.2015.06.025] [PMID: 26206243]
[30]
Wittkowski, H.; Frosch, M.; Wulffraat, N.; Goldbach-Mansky, R.; Kallinich, T.; Kuemmerle-Deschner, J.; Frühwald, M.C.; Dassmann, S.; Pham, T.H.; Roth, J.; Foell, D. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum., 2008, 58(12), 3924-3931.
[http://dx.doi.org/10.1002/art.24137] [PMID: 19035478]
[31]
Abdel-Maaboud, M.; El-Mazary, A-A.M.; Osman, A.M. Serum calprotectin as a diagnostic marker of late onset sepsis in full-term neonates. Egypt. J. Pediatr. Allergy Immunol., 2012, 10(1), 19-24.

Rights & Permissions Print Cite
Article Metrics
20
2
© 2024 Bentham Science Publishers | Privacy Policy